Keyphrases
Transcatheter Aortic Valve Replacement
69%
Severe Aortic Stenosis
32%
Transcatheter Aortic Valve Implantation
32%
Percutaneous Coronary Intervention
30%
Acute Coronary Syndrome
17%
ST-elevation Myocardial Infarction (STEMI)
13%
Heart Failure
12%
Drug-eluting Stent
11%
Clinical Outcomes
11%
Aortic Regurgitation
10%
Israeli
10%
Mitral Regurgitation
9%
Balloon-expandable
9%
Network Meta-analysis
9%
Consecutive Patients
9%
1-year Mortality
9%
Self-expanding Valve
8%
Odds Ratio
8%
Atrial Fibrillation
8%
Baseline Characteristics
8%
Israel
7%
Left Ventricular Ejection Fraction
7%
All-cause Mortality
7%
Acute Kidney Injury
7%
CoreValve
6%
Confidence Interval
6%
Stent
6%
Transfemoral
6%
Electrophysiological Study
6%
Clinical High Risk
6%
Mortality Prediction
6%
Femoropopliteal Lesions
6%
Angio-Seal
6%
Fractional Flow Reserve
6%
Eluting Stent
6%
Aortic Stenosis
6%
Acute Myocardial Infarction
6%
Hazard Ratio
6%
Myocardial Infarction Patients
5%
Post-procedural
5%
Artificial Intelligence
5%
Body Mass Index
5%
In-hospital Outcomes
5%
Peripheral Arterial Disease
5%
Bare Metal Stent
5%
Coronary Artery Disease
5%
In-stent Restenosis
5%
Transfemoral Access
5%
Intra-procedural
5%
P2Y12
5%
Medicine and Dentistry
Percutaneous Aortic Valve Replacement
100%
Aortic Stenosis
36%
Percutaneous Coronary Intervention
32%
Acute Coronary Syndrome
17%
Heart Failure
14%
Coronary Artery Disease
12%
Aortic Insufficiency
11%
Drug-Eluting Stent
11%
Myocardial Infarction
10%
ST Segment Elevation Myocardial Infarction
10%
Mitral Insufficiency
9%
Network Meta-Analysis
9%
Apoplexy
9%
Arteriosclerosis Obliterans
8%
Disease
7%
Hazard Ratio
7%
Cardiovascular System
7%
Atrial Fibrillation
7%
Odds Ratio
7%
Acute Kidney Injury
7%
In-Stent Restenosis
7%
Heart Left Ventricle Ejection Fraction
6%
All Cause Mortality
6%
Body Mass Index
6%
Hemodynamic
6%
Stent-Graft
6%
Fractional Flow Reserve
6%
Acute Heart Infarction
6%
Cardiogenic Shock
5%
Adverse Outcome
5%
Bleeding
5%
Ejection Fraction
5%
Critical Limb Ischemia
5%
Target Lesion Revascularization
5%
Randomized Controlled Trial
5%
Blood Stasis
5%
